Atypical femoral fractures and bisphosphonate use

New England Journal of Medicine

Volumn 362, Issue 19, 2010, Pages 1848-1849

  Girgis, Christian M ^a   Sher, Doron ^a   Seibel, Markus J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; RISEDRONIC ACID; DRUG DERIVATIVE; ETIDRONIC ACID;

BONE RADIOGRAPHY; DISEASE CLASSIFICATION; FEMUR SUBTROCHANTERIC FRACTURE; FRAGILITY FRACTURE; HUMAN; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT DURATION; AGED; CHEMICALLY INDUCED DISORDER; FEMALE; FEMUR FRACTURE; MALE; OSTEOPOROSIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALENDRONATE; DIPHOSPHONATES; ETIDRONIC ACID; FEMALE; FEMORAL FRACTURES; HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS;

EID: 77952307540     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0910389     Document Type: Letter

References (5)

1. Lee P, van der Wall H, Seibel MJ. Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy. J Endocrinol Invest 2007;30:590-597 (Pubitemid 47577812)
2. Lee P, Seibel MJ. More on atypical fractures of the femoral diaphysis. N Engl J Med 2008;359:317. (Pubitemid 352008465)
3. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008;22:346-350 (Pubitemid 351630250)
4. Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008;358:1304-1306 (Pubitemid 351439247)
5. Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 2009; 24:1095-1102.